Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-18 @ 6:42 AM
Study NCT ID:
NCT00343512
Status:
TERMINATED
Last Update Posted:
2012-04-27
First Post:
2006-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VICC BRE 0368
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |